Crinetics (CRNX) Reiterated at Market Outperform by Citizens

June 11, 2026 5:10 AM

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $95.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented, "Camurus ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found